180 related articles for article (PubMed ID: 36756642)
1. Proenkephalin A and bioactive adrenomedullin are useful for risk prognostication in cardiac surgery.
Hill A; Bergmann D; Schulte J; Zayat R; Marx G; Simon TP; Mossanen J; Brücken A; Stoppe C
Front Cardiovasc Med; 2022; 9():1017867. PubMed ID: 36756642
[TBL] [Abstract][Full Text] [Related]
2. 30 Days Mortality Prognostic Value of POCT Bio-Adrenomedullin and Proenkephalin in Patients with Sepsis in the Emergency Department.
Casalboni S; Valli G; Terlizzi F; Mastracchi M; Fidelio G; De Marco F; Bernardi C; Chieruzzi A; Curcio A; De Cicco F; Colella N; Papasidero ID; Tartarone E; Ruggieri MP; Di Somma S
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36556987
[No Abstract] [Full Text] [Related]
3. Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting.
Molvin J; Jujic A; Navarin S; Melander O; Zoccoli G; Hartmann O; Bergmann A; Struck J; Bachus E; Di Somma S; Magnusson M
Open Heart; 2019; 6(2):e001048. PubMed ID: 31354956
[TBL] [Abstract][Full Text] [Related]
4. Plasma proenkephalin A 119-159 and dipeptidyl peptidase 3 on admission after cardiac arrest help predict long-term neurological outcome.
Thorgeirsdóttir B; Levin H; Spångfors M; Annborn M; Cronberg T; Nielsen N; Lybeck A; Friberg H; Frigyesi A
Resuscitation; 2021 Jun; 163():108-115. PubMed ID: 33930500
[TBL] [Abstract][Full Text] [Related]
5. Utility of Measuring Circulating Bio-Adrenomedullin and Proenkephalin for 30-Day Mortality Risk Prediction in Patients with COVID-19 and Non-COVID-19 Interstitial Pneumonia in the Emergency Department.
Papasidero ID; Valli G; Marin D; Del Sasso A; De Magistris A; Cennamo E; Casalboni S; De Marco F; Rocchi R; Ndogmo Beumo B; Cusani V; Gaudio M; Hartmann O; Bergman A; Ruggieri MP; Di Somma S
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557054
[No Abstract] [Full Text] [Related]
6. The value of bioactive adrenomedullin and dipeptidyl peptidase 3 to predict short-term unfavourable outcomes after cardiac surgery: A prospective cohort study.
van Lier D; Beunders R; Kox M; Pickkers P
Eur J Anaesthesiol; 2022 Apr; 39(4):342-351. PubMed ID: 35102040
[TBL] [Abstract][Full Text] [Related]
7. PenKid measurement at admission is associated with outcome in severely ill burn patients.
Dépret F; Polina A; Amzallag J; Fayolle-Pivot L; Coutrot M; Chaussard M; Struck J; Hartmann O; Jully M; Fratani A; Oueslati H; Cupaciu A; Soussi S; Benyamina M; Guillemet L; Mebazaa A; Textoris J; Legrand M;
Burns; 2020 Sep; 46(6):1302-1309. PubMed ID: 31987659
[TBL] [Abstract][Full Text] [Related]
8. Proenkephalin A 119-159 predicts early and successful liberation from renal replacement therapy in critically ill patients with acute kidney injury: a post hoc analysis of the ELAIN trial.
von Groote T; Albert F; Meersch M; Koch R; Porschen C; Hartmann O; Bergmann D; Pickkers P; Zarbock A
Crit Care; 2022 Oct; 26(1):333. PubMed ID: 36316692
[TBL] [Abstract][Full Text] [Related]
9. Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness.
Lundberg OHM; Lengquist M; Spångfors M; Annborn M; Bergmann D; Schulte J; Levin H; Melander O; Frigyesi A; Friberg H
Crit Care; 2020 Nov; 24(1):636. PubMed ID: 33148300
[TBL] [Abstract][Full Text] [Related]
10. Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study.
Mebazaa A; Geven C; Hollinger A; Wittebole X; Chousterman BG; Blet A; Gayat E; Hartmann O; Scigalla P; Struck J; Bergmann A; Antonelli M; Beishuizen A; Constantin JM; Damoisel C; Deye N; Di Somma S; Dugernier T; François B; Gaudry S; Huberlant V; Lascarrou JB; Marx G; Mercier E; Oueslati H; Pickkers P; Sonneville R; Legrand M; Laterre PF;
Crit Care; 2018 Dec; 22(1):354. PubMed ID: 30583748
[TBL] [Abstract][Full Text] [Related]
11. Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock.
Tolppanen H; Rivas-Lasarte M; Lassus J; Sans-Roselló J; Hartmann O; Lindholm M; Arrigo M; Tarvasmäki T; Köber L; Thiele H; Pulkki K; Spinar J; Parissis J; Banaszewski M; Silva-Cardoso J; Carubelli V; Sionis A; Harjola VP; Mebazaa A
Ann Intensive Care; 2017 Dec; 7(1):6. PubMed ID: 28050899
[TBL] [Abstract][Full Text] [Related]
12. Plasma proenkephalin A 119-159 on intensive care unit admission is a predictor of organ failure and 30-day mortality.
Frigyesi A; Boström L; Lengquist M; Johnsson P; Lundberg OHM; Spångfors M; Annborn M; Cronberg T; Nielsen N; Levin H; Friberg H
Intensive Care Med Exp; 2021 Jul; 9(1):36. PubMed ID: 34278538
[TBL] [Abstract][Full Text] [Related]
13. Incidence and Outcome of Subclinical Acute Kidney Injury Using penKid in Critically Ill Patients.
Dépret F; Hollinger A; Cariou A; Deye N; Vieillard-Baron A; Fournier MC; Jaber S; Damoisel C; Lu Q; Monnet X; Rennuit I; Darmon M; Leone M; Guidet B; Sonneville R; Montravers P; Pili-Floury S; Lefrant JY; Duranteau J; Laterre PF; Brechot N; Oueslati H; Cholley B; Struck J; Hartmann O; Mebazaa A; Gayat E; Legrand M
Am J Respir Crit Care Med; 2020 Sep; 202(6):822-829. PubMed ID: 32516543
[No Abstract] [Full Text] [Related]
14. Circulating Proenkephalin, Acute Kidney Injury, and Its Improvement in Patients with Severe Sepsis or Shock.
Caironi P; Latini R; Struck J; Hartmann O; Bergmann A; Bellato V; Ferraris S; Tognoni G; Pesenti A; Gattinoni L; Masson S;
Clin Chem; 2018 Sep; 64(9):1361-1369. PubMed ID: 30012641
[TBL] [Abstract][Full Text] [Related]
15. The role of Proenkephalin A 119-159 in the detection of acute kidney injury after open thoracoabdominal aortic repair.
Doukas P; Hartmann O; Arlt B; Jacobs MJ; Greiner A; Frese JP; Gombert A
Vasa; 2024 Jan; 53(1):61-67. PubMed ID: 37965700
[No Abstract] [Full Text] [Related]
16. Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) Study.
Hollinger A; Wittebole X; François B; Pickkers P; Antonelli M; Gayat E; Chousterman BG; Lascarrou JB; Dugernier T; Di Somma S; Struck J; Bergmann A; Beishuizen A; Constantin JM; Damoisel C; Deye N; Gaudry S; Huberlant V; Marx G; Mercier E; Oueslati H; Hartmann O; Sonneville R; Laterre PF; Mebazaa A; Legrand M
Kidney Int Rep; 2018 Nov; 3(6):1424-1433. PubMed ID: 30450469
[TBL] [Abstract][Full Text] [Related]
17. Proenkephalin a 119-159 (penKid) - a novel biomarker for acute kidney injury in sepsis: an observational study.
Rosenqvist M; Bronton K; Hartmann O; Bergmann A; Struck J; Melander O
BMC Emerg Med; 2019 Nov; 19(1):75. PubMed ID: 31779591
[TBL] [Abstract][Full Text] [Related]
18. Bioactive adrenomedullin (bio-ADM) is associated with endothelial dysfunction in infants and children with complex congenital heart disease undergoing open-heart surgery on cardiopulmonary bypass.
Schaefer M; Stein A; Ruf B; Balling G; Palm J; Simmelbauer A; Cleuziou J; Sander M; Auer J; Borgmann K; Struck J; Hartmann O; Schulte J; Hörer J; Tassani-Prell P; Ewert P; Holdenrieder S; Wolf CM
Clin Chem Lab Med; 2024 Feb; 62(3):551-561. PubMed ID: 37870269
[TBL] [Abstract][Full Text] [Related]
19. Postoperatively increased bioactive adrenomedullin is related to adverse outcome after complex aortic surgery.
Gombert A; Doukas P; Marx G; Hartmann O; Bergmann D; Schulte J; Stoppe C; Jacobs M; Simon T
Vasa; 2020 Apr; 49(3):187-194. PubMed ID: 32011218
[No Abstract] [Full Text] [Related]
20. Evaluation of Proenkephalin A 119-159 for liberation from renal replacement therapy: an external, multicenter pilot study in critically ill patients with acute kidney injury.
von Groote T; Albert F; Meersch M; Koch R; Gerss J; Arlt B; Sadjadi M; Porschen C; Pickkers P; Zarbock A;
Crit Care; 2023 Jul; 27(1):276. PubMed ID: 37430375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]